Skip to main content
Evaluation of an early step-down strategy from intravenous anidulafungin to oral azole therapy for the treatment of candidemia and other forms of invasive candidiasis: Results from an open-label trial
Published Web Location
http://europepmc.org/articles/PMC3944438?pdf=renderNo data is associated with this publication.
Abstract
Background: Hospitalized patients are at increased risk for candidemia and invasive candidiasis (C/IC). Improved therapeutic regimens with enhanced clinical and pharmacoeconomic outcomes utilizing existing antifungal agents are still needed.Methods: An ope
Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.